Biotech Center awards $6.3m in loans, grants across state over past year

Posted by on Jul 31, 2014 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. — The North Carolina Biotechnology Center awarded more than $1.5 million in the fourth quarter of its 2013-2014 fiscal year, while the Center’s loan recipients brought in more than $77 million in outside funding during the period. NCBiotech approved 22 loans and grants in nine programs to institutions and organizations across the state during the quarter running from April through June, 2014. For the full year, NCBiotech awarded 78 loans and grants totaling $6,308,186.The awards program supports life science entrepreneurship, technology commercialization...

Read More

Florida Institute Funds Miami-based RxMP Therapeutics, LLC

Posted by on Jul 31, 2014 in Newsroom | 0 comments

GAINESVILLE & BOCA RATON, FL. - The Institute for Commercialization of Public Research (the Institute) announced on July 30th, that it has finalized a funding agreement with RxMP Therapeutics, LLC, an emerging pharmaceutical company based in Miami. The Institute supports new company creation based on publicly-funded research, and bridges early funding gaps for companies spinning out of Florida-based universities and research institutions. “By reducing or even eliminating blood transfusions in cases of excessive bleeding, RMP-HPE should limit patients’ exposure to these serious...

Read More

OBMedical Company nabs $2.1 mln

Posted by on Jul 30, 2014 in Newsroom | 0 comments

GAINESVILLE, FL. - New World Angels (“NWA”), Florida’s premier structured angel investor group, led an investment in the OBMedical Company totaling $2.1 Million, joined by the Angel Investment Management Group (“AIM Group”), an Alabama-headquartered network of angel networks, Atlanta Technology Angels (“ATA”), a member led angel network for early stage technology companies in Georgia and the Southeast, the Upstate Carolina Angel Network (“UCAN”), a group of accredited investors located in Upstate South Carolina; and the Palmetto Angel 2014 Fund, an early stage investment...

Read More

UF Tech Connect Program continuing to reap investments, add jobs

Posted by on Jul 22, 2014 in Newsroom | 0 comments

GAINESVILLE, FL - The University of Florida’s Tech Connect Program has racked up an impressive list of accomplishments in its first 12 years. The program helped spin off 157 companies using technology created by UF researchers, the UF Office of Technology Licensing reported Monday. Those companies have drawn more than $1 billion in private investments and $530 million in public grants, and helped create 2,000 new jobs, the OTL reported. In the past 12 months alone, companies associated with Tech Connect helped create 345 new jobs and raised more than $200 million in private and public...

Read More

Agile Sciences lands $1.5M NIH grant for cystic fribosis therapy

Posted by on Jul 17, 2014 in Newsroom | 0 comments

RESEARCH TRIANGLE PARK, N.C. – Biotechnology company Agile Sciences has landed a $1.5 million National Institutes of Health grant to help develop its cystic fibrosis therapy derived from sea sponges. Agile was spun out of North Carolina State University with the help of a $30,000 startup loan from the North Carolina Biotechnology Center. The company’s technology platform capitalizes on a chemical produced by the sea sponge to break up bacterial clumps called biofilms. The latest NIH grant supports pre-clinical development of Agile’s proprietary Agilyte anti-biofilm molecules for...

Read More

IRadimed Corporation Announces Pricing of Initial Public Offering

Posted by on Jul 17, 2014 in Newsroom | 0 comments

WINTER SPRINGS, FL. - IRADIMED CORPORATION (NASDAQ:IRMD), the leading provider of non-magnetic intravenous (IV) infusion pump systems that are safe for use during magnetic resonance imaging (MRI) procedures, announced today the pricing of its initial public offering of 2,016,000 shares of its common stock at an initial public offering price of $6.25 per share for a total offering amount of $12.6 million before deducting underwriting discounts and commissions, and estimated offering expenses payable by Iradimed. In addition, the underwriters have been granted a 45-day option to purchase up to...

Read More